Dilly Stephen George

Officer, Director at CDXS; Director at SGMO; President and CEO at Aimmune Therapeutics, Inc.

Sold, on record
$21.8M
Dollars the filings state
Form 4 sales
14
Latest Mar 8, 2023
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Aimmune Therapeutics, Inc.Plan not stated
    Oct 16 2017

    Sold 1,154 shares at $26.24 ($30k)

    Dilly Stephen George, President and CEO

    Sold 0.3% of holdings ($10.9M position)415,308 shares left0x usual sizeFiling

  2. 2 Form 4 sale Aimmune Therapeutics, Inc.Plan not stated
    Oct 23 +7 days

    Sold 100,000 shares at $33.54 ($3.4M)

    Dilly Stephen George, Officer, Director

    Sold 24.1% of holdings ($13.9M position)315,308 shares left2x usual sizeFiling

  3. 3 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Jun 5 +225 days

    Sold 165,374 shares at $32.14 ($5.3M)

    Dilly Stephen George, Officer, Director

    Sold 34.4% of holdings ($15.4M position)315,308 shares left3.3x usual sizeFiling

  4. 4 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Jun 8 +3 days

    Sold 105,169 shares at $30.93 ($3.3M)

    Dilly Stephen George, President and CEO

    Sold 25% of holdings ($13M position)315,308 shares left2.1x usual sizeFiling

  5. 5 Form 4 sale Aimmune Therapeutics, Inc.Plan not stated
    Jun 11 +3 days

    Sold 29,457 shares at $30.83 ($908k)

    Dilly Stephen George, President and CEO

    Sold 8.5% of holdings ($10.6M position)315,308 shares left0.4x usual sizeFiling

  6. 6 Form 4 sale SGMOUnusual
    Mar 16 +644 days

    Sold 15,000 shares at $6.02 ($90k)

    Dilly Stephen George, Director

    Sold 75% of holdings ($120k position)5,000 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale SGMOUnusual
    Mar 19 +3 days

    Sold 35,000 shares at $6.00 ($210k)

    Dilly Stephen George, Director

    Sold 87.5% of holdings ($240k position)5,000 shares leftFiling

  8. 8 Form 4 sale CDXSPlan not stated
    Mar 8 +1084 days

    Sold 55,075 shares at $4.58 ($252k)

    Dilly Stephen George, Officer, Director

    Sold 12.6% of holdings ($2M position)380,399 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Dilly Stephen George
Source
Mar 8, 2023CDXSOfficer, DirectorForm 4 sale55,075$252k12.6%Plan not statedSEC
Mar 19, 2020SGMODirectorForm 4 sale35,000$210k87.5%UnusualSEC
Mar 16, 2020SGMODirectorForm 4 sale15,000$90k75.0%UnusualSEC
Jun 11, 2018Aimmune Therapeutics, Inc.President and CEOForm 4 sale29,457$908k8.5%Plan not statedSEC
Jun 8, 2018Aimmune Therapeutics, Inc.President and CEOForm 4 sale105,169$3.3M25.0%UnusualSEC
Jun 5, 2018Aimmune Therapeutics, Inc.Officer, DirectorForm 4 sale165,374$5.3M34.4%UnusualSEC
Oct 23, 2017Aimmune Therapeutics, Inc.Officer, DirectorForm 4 sale100,000$3.4M24.1%Plan not statedSEC
Oct 16, 2017Aimmune Therapeutics, Inc.President and CEOForm 4 sale1,154$30k0.3%Plan not statedSEC
Oct 6, 2017Aimmune Therapeutics, Inc.President and CEOForm 4 sale98,846$2.6M19.2%Plan not statedSEC
Sep 25, 2017Aimmune Therapeutics, Inc.President and CEOForm 4 sale100,000$2.5M16.3%Plan not statedSEC
Jul 26, 2017Aimmune Therapeutics, Inc.President and CEOForm 4 sale50,000$1.1M7.5%Plan not statedSEC
Jun 23, 2017Aimmune Therapeutics, Inc.President and CEOForm 4 sale49,400$998k6.9%Plan not statedSEC
May 10, 2017Aimmune Therapeutics, Inc.Officer, DirectorForm 4 sale600$12k0.1%Plan not statedSEC
Nov 11, 2016Aimmune Therapeutics, Inc.Officer, DirectorForm 4 sale50,000$1.3M6.5%Plan not statedSEC